Roger Gunn
Invicro
Roger Gunn is Executive Vice President, Quantitative Data Science for Invicro, and Professor of Molecular Neuroimaging in the Division of Brain Sciences at Imperial College London.
He is currently working on an experimental medicine study for Dementias Platform UK examining 'glial' cells and their role in Alzheimer's disease.
He is also part of the Dementias Platform UK imaging network, and DPUK's Company Partner Forum.
Recent publications
-
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Koychev, Ivana; Gunn, Roger N | Firouzian, Azadeh | Lawson, Jennifer | Zamboni, Giovanna | Ridha, Basil | Sahakian, Barbara J | Rowe, James B| Thomas, Alan | Rochester, Lynn | Ffytche, Dominic | Howard, Robert | Zetterberg, Henriki | MacKay, Clare| Lovestone, Simon | on behalf of the Deep and Frequent Phenotyping study team , (2018), Journal of Alzheimer's Disease
-
Gait in Mild Alzheimer’s Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study
Journal article
Mc Ardle, Ríona et al, (2018), Journal of Alzheimer's Disease, 63, 331 - 341
-
Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.
Journal article
Firouzian A et al, (2018), 8
-
PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Journal article
Koychev, Ivan et al, (2017), Journal of Alzheimer's Disease, 60, 283 - 293